Live Breaking News & Updates on Therapeutics advisory panel

Formal and informal science advice in emergencies: COVID-19 in the UK

The importance of scientific advice to government gains greater recognition in emergencies but inevitably has to be done in an environment of uncertainty, with limited data and at high speed. Adapt.

United-kingdom , Porton-down , Wiltshire , Japan , United-states , India , Singapore , China , South-korea , Scotland , Scientific-pandemic-influenza-group-on-modelling

TLSA: Intranasal Foralumab in COVID-19

TLSA: Intranasal Foralumab in COVID-19
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Brazil , Japan , United-kingdom , Switzerland , Swiss , John-vandermosten , Kevin-schutz , Tiziana-life-sciences-corporate-presentation , Therapeutics-advisory-panel , Regulatory-affairs , Nasdaq , Regulatory-affairs-on

Midlands is delivering nearly £100m of COVID research to support nation's fight against COVID-19


Date Time
Midlands is delivering nearly £100m of COVID research to support nation’s fight against COVID-19
A new report – Mobilising Research Excellence in the Midlands to Tackle COVID-19 – published today (Friday, January 15 2021) reveals that the Midlands has moved swiftly to apply its wealth of capability in its hospitals, businesses and universities, including the University of Warwick, to deliver £90m of research to support regional, national and global efforts to tackle the Coronavirus Pandemic.
The report highlights that:
Experts in the Midlands are leading 81 new COVID-19 research programmes.
The region is playing a crucial and integral role in the world-leading genome sequencing consortium which is identifying the strains of COVID-19 recently in the UK and internationally.

Leicester , United-kingdom , Leicestershire , Midlands , Nottingham , London , City-of , Ian-hall , Darren-clark , Clinical-research-networks , Patient-recruitment-centre , University-of-oxford-astrazeneca-united-kingdom